Zogenix Inc. (ZGNX)

39.55
0.40 1.02
NASDAQ : Health Technology
Prev Close 39.15
Open 39.35
Day Low/High 38.65 / 39.75
52 Wk Low/High 10.05 / 45.85
Volume 296.75K
Avg Volume 496.10K
Exchange NASDAQ
Shares Outstanding 34.97M
Market Cap 1.37B
EPS -4.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Choppy Market Action This Morning

Choppy Market Action This Morning

The good news is that there is some stock picking that is working well.

How Will the Market Trade at this Point?

How Will the Market Trade at this Point?

Will we see a trading range develop or will there be a continued effort to trend back to the recent highs?

Zogenix Announces Receipt Of FDA Breakthrough Therapy Designation For ZX008 In Dravet Syndrome

Zogenix Announces Receipt Of FDA Breakthrough Therapy Designation For ZX008 In Dravet Syndrome

Designation Based on Positive Results from Study 1, the First Pivotal Phase 3 Trial of ZX008

First Week of March 16th Options Trading For Zogenix (ZGNX)

First Week of March 16th Options Trading For Zogenix (ZGNX)

Investors in Zogenix Inc. saw new options become available this week, for the March 16th expiration.

Noteworthy Monday Option Activity: ZGNX, TTWO, HIIQ

Noteworthy Monday Option Activity: ZGNX, TTWO, HIIQ

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 5,943 contracts have traded so far, representing approximately 594,300 underlying shares.

Notable Thursday Option Activity: ZGNX, AMAG, FNSR

Notable Thursday Option Activity: ZGNX, AMAG, FNSR

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 4,378 contracts have traded so far, representing approximately 437,800 underlying shares.

Selling Subsides, but Market's Still a Mess

Selling Subsides, but Market's Still a Mess

Facebook, Alibaba sell off on very good reports.

Don't Expect a Strong Market to Suddenly Collapse

Don't Expect a Strong Market to Suddenly Collapse

Until we have some sort of dip, it won't be simple to find new buys.

Extended Market Makes Finding Entry Points Tough

Extended Market Makes Finding Entry Points Tough

There is just no logical way to gauge how much further this market can run even when it is technically extended by most measures.

Zogenix Reaches Analyst Target Price

Zogenix Reaches Analyst Target Price

In recent trading, shares of Zogenix Inc. have crossed above the average analyst 12-month target price of $24.67, changing hands for $35.05/share.

These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.

Wall Street Closes Out Third Quarter With Records for S&P 500, Nasdaq

Wall Street Closes Out Third Quarter With Records for S&P 500, Nasdaq

The S&P 500 reaches new records on Friday, Sept. 29, closing at all-time highs for the second day in a row.

S&P 500 Touches New Intraday Record, on Track for Sixth Straight Monthly Gain

S&P 500 Touches New Intraday Record, on Track for Sixth Straight Monthly Gain

The S&P 500 reaches new records on Friday, Sept. 29, and is on track to close at all-time highs for the second day in a row.

Atypical September Finishing the Way It Started

Atypical September Finishing the Way It Started

Six big Friday movers are on my radar.

TheStreet Quant Rating: D (Sell)